|
1
|
No authors listed. A novel gene containing
a trinucleotide repeat that is expanded and unstable on
Huntington’s disease chromosomes. The Huntington’s Disease
Collaborative Research Group. Cell. 72:971–983. 1993.
|
|
2
|
Gusella JF, MacDonald ME, Ambrose CM and
Duyao MP: Molecular genetics of Huntington’s disease. Arch Neurol.
50:1157–1163. 1993.
|
|
3
|
Vonsattel JP and DiFiglia M: Huntington
disease. J Neuropathol Exp Neurol. 57:369–384. 1998. View Article : Google Scholar
|
|
4
|
Kim YJ, Yi Y, Sapp E, et al: Caspase
3-cleaved N-terminal fragments of wild-type and mutant huntingtin
are present in normal and Huntington’s disease brains, associate
with membranes, and undergo calpain-dependent proteolysis. Proc
Natl Acad Sci USA. 98:12784–12789. 2001.PubMed/NCBI
|
|
5
|
Ho LW, Carmichael J, Swartz J, Wyttenbach
A, Rankin J and Rubinsztein DC: The molecular biology of
Huntington’s disease. Psychol Med. 31:3–14. 2001.
|
|
6
|
Gauthier LR, Charrin BC, Borrell-Pages M,
et al: Huntingtin controls neurotrophic support and survival of
neurons by enhancing BDNF vesicular transport along microtubules.
Cell. 118:127–138. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morton AJ and Edwardson JM: Progressive
depletion of complexin II in a transgenic mouse model of
Huntington’s disease. J Neurochem. 76:166–172. 2001.PubMed/NCBI
|
|
8
|
Berger Z, Ravikumar B, Menzies FM, et al:
Rapamycin alleviates toxicity of different aggregate-prone
proteins. Hum Mol Genet. 15:433–442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Floto RA, Sarkar S, Perlstein EO, Kampmann
B, Schreiber SL and Rubinsztein DC: Small molecule enhancers of
rapamycin-induced TOR inhibition promote autophagy, reduce toxicity
in Huntington’s disease models and enhance killing of mycobacteria
by macrophages. Autophagy. 3:620–622. 2007.PubMed/NCBI
|
|
10
|
Sarkar S, Davies JE, Huang Z, Tunnacliffe
A and Rubinsztein DC: Trehalose, a novel mTOR-independent autophagy
enhancer, accelerates the clearance of mutant huntingtin and
alpha-synuclein. J Biol Chem. 282:5641–5652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sarkar S, Perlstein EO, Imarisio S, et al:
Small molecules enhance autophagy and reduce toxicity in
Huntington’s disease models. Nat Chem Biol. 3:331–338.
2007.PubMed/NCBI
|
|
12
|
Li X, Wang CE, Huang S, Xu X, Li XJ, Li H
and Li S: Inhibiting the ubiquitin-proteasome system leads to
preferential accumulation of toxic N-terminal mutant huntingtin
fragments. Hum Mol Genet. 19:2445–2455. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li W, Yang Q and Mao Z: Chaperone-mediated
autophagy: machinery, regulation and biological consequences. Cell
Mol Life Sci. 68:749–763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cuervo AM, Knecht E, Terlecky SR and Dice
JF: Activation of a selective pathway of lysosomal proteolysis in
rat liver by prolonged starvation. Am J Physiol. 269:C1200–C1208.
1995.PubMed/NCBI
|
|
15
|
Agarraberes FA, Terlecky SR and Dice JF:
An intralysosomal hsp70 is required for a selective pathway of
lysosomal protein degradation. J Cell Biol. 137:825–834. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cuervo AM and Dice JF: Regulation of
lamp2a levels in the lysosomal membrane. Traffic. 1:570–583. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carra S, Brunsting JF, Lambert H, Landry J
and Kampinga HH: HspB8 participates in protein quality control by a
non-chaperone-like mechanism that requires eIF2{alpha}
phosphorylation. J Biol Chem. 284:5523–5532. 2009.PubMed/NCBI
|
|
18
|
Bauer PO, Goswami A, Wong HK, et al:
Harnessing chaperone-mediated autophagy for the selective
degradation of mutant huntingtin protein. Nat Biotechnol.
28:256–263. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Li H and Li XJ: Intracellular
degradation of misfolded proteins in polyglutamine
neurodegenerative diseases. Brain Res Rev. 59:245–252. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koga H, Martinez-Vicente M, Arias E,
Kaushik S, Sulzer D and Cuervo AM: Constitutive upregulation of
chaperone-mediated autophagy in Huntington’s disease. J Neurosci.
31:18492–18505. 2011.PubMed/NCBI
|
|
21
|
Qi L, Zhang XD, Wu JC, Lin F, Wang J,
DiFiglia M and Qin ZH: The role of chaperone-mediated autophagy in
huntingtin degradation. PLoS One. 7:e468342012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi L and Zhang XD: Role of
chaperone-mediated autophagy in degrading Huntington’s
disease-associated huntingtin protein. Acta Biochim Biophys Sin
(Shanghai). 46:83–91. 2014.
|
|
23
|
Baldo B, Soylu R and Petersen A:
Maintenance of basal levels of autophagy in Huntington’s disease
mouse models displaying metabolic dysfunction. PLoS One.
8:e830502013.PubMed/NCBI
|
